TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/17/25 16:01 | 9/17/25 | OBLG | Oblong, Inc. | DE | Tech | Softw | Computer Programming, Data Pr | Schechter Jonathan | CO | D | P.d | 13 | 2.70 | 0 | 5 | 50 | 15 | D | |||||||||||||||
9/16/25 15:59 | 9/16/25 | OBLG | Oblong, Inc. | DE | Tech | Softw | Computer Programming, Data Pr | Schechter Jonathan | CO | D | P.d | 27 | 2.73 | 0 | 10 | New | 10 | D | |||||||||||||||
12/20/22 20:01 | 12/16/22 | SNPX | Synaptogenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Schechter Jonathan | NY | D | S | -24 | 1.17 | 0 | -20 | -42 | 29 | D | |||||||||||||||
11/2/20 09:01 | 10/30/20 | NTRP | Neurotrope, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Schechter Jonathan | NY | D | P | 24 | 0.9777 | 0 | 25 | 50 | 75 | D | |||||||||||||||
10/26/20 09:00 | 10/22/20 | NTRP | Neurotrope, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Schechter Jonathan | NY | D | P | 28 | 1.10 | 0 | 25 | 100 | 50 | D | |||||||||||||||
10/22/20 09:00 | 10/20/20 | NTRP | Neurotrope, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Schechter Jonathan | NY | D | P.m | 28 | 1.10 | 0 | 25 | New | 25 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |